Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. The company utilizes a proprietary discovery platform that incorporates high resolution genomic analyses, in-house machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains that have immune activation and pathogen inhibition properties in respiratory tissues. Resilient Biotics has a broad pipeline of actives addressing both viral and bacterial infectious diseases including positive in vivo efficacy data across multiple species.
Company Details
- Employees
- 11
- Address
- 2 Davis Drive, Durham,nc 27709,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.resilientbiotics.com
- Keywords
- Microbiome and Respiratory Health.
- HQ
- Durham, NC
Resilient Biotics Questions
Resilient Biotics's website is http://www.resilientbiotics.com
Resilient Biotics's LinkedIn profile is https://www.linkedin.com/company/resilient-biotics
Resilient Biotics has
11 employees.
View email and phone details for 11
employees at Resilient Biotics.
Resilient Biotics's industry is
Biotechnology Research
Resilient Biotics's top competitors are
Fabp Biotech,
Verovaccines Gmbh,
Onecup Ai,
Stmpatch - Singletimemicroneedles,
Peptidus Biotech,
Organicin Scientific,
Second Genome Inc.,
Astra Therapeutics,
Locus Biosciences, Inc.,
Novus International, Inc..
Resilient Biotics's categories are Biotechnology Research
